# Clinical Tolerance and Equivalence of hCG-IBSA vs Recombinant Human Chorionic Gonadotrophin in Women Undergoing In Vitro Fertilisation

> **NCT00335569** · PHASE3 · COMPLETED · sponsor: **IBSA Institut Biochimique SA** · enrollment: 144 (estimated)

## Conditions studied

- Infertility

## Interventions

- **DRUG:** hCG-IBSA

## Key facts

- **NCT ID:** NCT00335569
- **Lead sponsor:** IBSA Institut Biochimique SA
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-08
- **Primary completion:** —
- **Final completion:** 2008-12
- **Target enrollment:** 144 (ESTIMATED)
- **Last updated:** 2011-06-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00335569

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00335569, "Clinical Tolerance and Equivalence of hCG-IBSA vs Recombinant Human Chorionic Gonadotrophin in Women Undergoing In Vitro Fertilisation". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00335569. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*